RU2718923C2 - Низкомолекулярные производные карбоксамидных галогенированных порфиринов, а именно хлоринов и бактериохлоринов, и их применения - Google Patents

Низкомолекулярные производные карбоксамидных галогенированных порфиринов, а именно хлоринов и бактериохлоринов, и их применения Download PDF

Info

Publication number
RU2718923C2
RU2718923C2 RU2017138871A RU2017138871A RU2718923C2 RU 2718923 C2 RU2718923 C2 RU 2718923C2 RU 2017138871 A RU2017138871 A RU 2017138871A RU 2017138871 A RU2017138871 A RU 2017138871A RU 2718923 C2 RU2718923 C2 RU 2718923C2
Authority
RU
Russia
Prior art keywords
hydrogen
formula
independently selected
atoms
derivatives
Prior art date
Application number
RU2017138871A
Other languages
English (en)
Russian (ru)
Other versions
RU2017138871A3 (https=
RU2017138871A (ru
Inventor
НАШСИМЕНТУ КОШТА Гонсалу ПЕРЕЙРА
ГОНСАЛВЕС Нуну Паулу ФЕРРЕЙРА
МУНТЕЙРУ Карлуш Жорже ПЕРЕЙРА
ДИ АБРЕУ Артур Карлуш РЕЙШ
КАРДОЗУ СОАРЕШ Элдер Тан ФЕРРАШ
РОКА Луиш Габриел БОРЖИШ
Фабио Антонио СКАБЕРЛЕ
ПЕРЕЙРА Мария МИГЕНШ
СИЛВА АРНАУТ МОРЕЙРА Луиш Гильерме ДА
Original Assignee
Лузитин, С.А.
Универсидаде Ди Коимбра
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лузитин, С.А., Универсидаде Ди Коимбра filed Critical Лузитин, С.А.
Publication of RU2017138871A publication Critical patent/RU2017138871A/ru
Publication of RU2017138871A3 publication Critical patent/RU2017138871A3/ru
Application granted granted Critical
Publication of RU2718923C2 publication Critical patent/RU2718923C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0093—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy
    • A61B5/0095—Detecting, measuring or recording by applying one single type of energy and measuring its conversion into another type of energy by applying light and detecting acoustic waves, i.e. photoacoustic measurements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acoustics & Sound (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2017138871A 2015-05-07 2016-05-06 Низкомолекулярные производные карбоксамидных галогенированных порфиринов, а именно хлоринов и бактериохлоринов, и их применения RU2718923C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT108447 2015-05-07
PT10844715 2015-05-07
PCT/IB2016/052606 WO2016178191A1 (en) 2015-05-07 2016-05-06 Low molecular weight derivatives of carboxamide halogenated porphyrins, namely chlorins and bacteriochlorins, and their applications thereof

Publications (3)

Publication Number Publication Date
RU2017138871A RU2017138871A (ru) 2019-06-10
RU2017138871A3 RU2017138871A3 (https=) 2019-06-11
RU2718923C2 true RU2718923C2 (ru) 2020-04-15

Family

ID=56084187

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017138871A RU2718923C2 (ru) 2015-05-07 2016-05-06 Низкомолекулярные производные карбоксамидных галогенированных порфиринов, а именно хлоринов и бактериохлоринов, и их применения

Country Status (11)

Country Link
US (1) US10450322B2 (https=)
EP (1) EP3292129B1 (https=)
JP (1) JP6730319B2 (https=)
CN (1) CN107624114B (https=)
AU (1) AU2016259188B2 (https=)
BR (1) BR112017023948A2 (https=)
CA (1) CA2985187C (https=)
HK (1) HK1245254A1 (https=)
RU (1) RU2718923C2 (https=)
WO (1) WO2016178191A1 (https=)
ZA (1) ZA201707533B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214637A1 (en) 2016-06-10 2017-12-14 Nirvana Sciences Inc. Hydroporphyrin beads with narrow fluorescence emissions
CN110662748A (zh) * 2017-02-03 2020-01-07 尼尔瓦纳科学股份有限公司 用于光声成像的氢卟啉
US11904026B2 (en) 2017-02-03 2024-02-20 Nirvana Sciences Inc. Metallohydroporphyrins for photoacoustic imaging
CN109912607B (zh) * 2018-12-11 2021-01-22 南华大学 一类卟啉-白杨素复合物及其抗肿瘤活性
SG10201811547RA (en) * 2018-12-21 2020-07-29 Oreal Cosmetic use of a short chain fatty acid (scfa) for preventing and/or treating dry skin and/or aged skin
CN109651383B (zh) * 2019-01-25 2021-11-16 华东理工大学 用于光敏剂的化合物及其应用
WO2020236828A1 (en) * 2019-05-20 2020-11-26 Nirvana Sciences Inc. Narrow emission dyes, compositions comprising same, and methods for making and using same
US12570665B2 (en) 2019-06-10 2026-03-10 University Of Massachusetts Compositions comprising fullerenyl mesochlorin nano-photosensitizers with covalently bound antibiotics and their uses in combination therapy
CN116354970B (zh) * 2023-03-28 2024-06-18 大连理工大学 一种卟啉类一氧化碳前药的制备方法及气体-声动力联合治疗应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2399622C2 (ru) * 2004-11-16 2010-09-20 Универсидади Ди Коймбра Новые производные порфиринов, в частности хлорины и/или бактериохлорины, и их применение в фотодинамической терапии
WO2011099602A1 (ja) * 2010-02-12 2011-08-18 学校法人日本大学 ポルフィリン誘導体および放射線力学療法におけるその使用
US20120289492A1 (en) * 2009-09-02 2012-11-15 The Regents Of The University Of Colorado, A Body Corporate Methods of treating mitochondrial disorders using metalloporphyrins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1480638A2 (en) * 2002-01-08 2004-12-01 Emory University Porphyrins with virucidal activity
GB0819594D0 (en) * 2008-10-24 2008-12-03 Univ Coimbrra Process
BR112013001576A2 (pt) * 2010-07-22 2016-07-19 Ceramoptec Gmbh composto tetrapirrólico e composição farmacêutica derivado farmacêuticamente aceitável da mesma e respectivos usos e métodos de terapia fotodinâmica e de diagnóstico e tratamento da artrite e de doenças inflamatórias semelhantes.
CN102166182A (zh) * 2011-01-24 2011-08-31 上海交通大学 纳米探针及其在肿瘤诊断组合物和光动力疗法中的应用
US10456375B2 (en) * 2014-09-30 2019-10-29 Biolitec Unternehmensbeteiligungs Ii Ag Specifically meso-substituted porphyrins and chlorins for photodynamic therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2399622C2 (ru) * 2004-11-16 2010-09-20 Универсидади Ди Коймбра Новые производные порфиринов, в частности хлорины и/или бактериохлорины, и их применение в фотодинамической терапии
US20120289492A1 (en) * 2009-09-02 2012-11-15 The Regents Of The University Of Colorado, A Body Corporate Methods of treating mitochondrial disorders using metalloporphyrins
WO2011099602A1 (ja) * 2010-02-12 2011-08-18 学校法人日本大学 ポルフィリン誘導体および放射線力学療法におけるその使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TOSHIKATSU T. et al., An efficient one-pot procedure for asymmetric bifunctionalization of 5,15-disubstituted porphyrins: a simple preparation of meso acyl-, alkoxycarbonyl-, and carbamoyl-substituted meso-formylporphyrins, Chem. Commun., 2009, p. 101-103, DOI: 10.1039/b817551a. *

Also Published As

Publication number Publication date
AU2016259188A1 (en) 2017-11-30
WO2016178191A1 (en) 2016-11-10
CN107624114A (zh) 2018-01-23
RU2017138871A3 (https=) 2019-06-11
BR112017023948A2 (en) 2018-07-24
JP6730319B2 (ja) 2020-07-29
JP2018515498A (ja) 2018-06-14
HK1245254A1 (zh) 2018-08-24
US10450322B2 (en) 2019-10-22
EP3292129A1 (en) 2018-03-14
CN107624114B (zh) 2021-03-23
AU2016259188B2 (en) 2019-10-31
ZA201707533B (en) 2019-04-24
RU2017138871A (ru) 2019-06-10
US20180282344A1 (en) 2018-10-04
CA2985187C (en) 2024-01-02
EP3292129B1 (en) 2019-03-27
CA2985187A1 (en) 2016-11-10

Similar Documents

Publication Publication Date Title
RU2718923C2 (ru) Низкомолекулярные производные карбоксамидных галогенированных порфиринов, а именно хлоринов и бактериохлоринов, и их применения
CN102227432B (zh) 制备二氢卟酚的方法及它们的医药用途
CN105008372A (zh) 在光动力疗法和诊断中有用的二氢卟酚衍生物
JPWO2012153493A1 (ja) 赤外域光による光線力学的治療又は診断剤
RU2712266C9 (ru) Атропоизомеры галогенированных тетрафенилбактериохлоринов и хлоринов и их применение в фотодинамической терапии
Warszynska et al. Better in the near infrared: Sulfonamide perfluorinated-phenyl photosensitizers for improved simultaneous targeted photodynamic therapy and real-time fluorescence imaging
JP2024537897A (ja) 分解可能な近赤外光増感剤、並びにその調製方法および使用
Wang et al. Synthesis and evolution of S-Porphin sodium as a potential antitumor agent for photodynamic therapy against breast cancer
KR20250153354A (ko) 상자성 이온이 결합된 프탈로시아닌 화합물을 포함하는 초음파 감작제 조성물 및 이의 용도
CN120209003A (zh) 一类无重原子且具有聚集诱导发射能力的i型双光子光敏剂及其制备方法与应用
Yan EVALUATION OF PORPHYRIN DERIVATIVE FOR PHOTODYNAMIC THERAPY
de Oliveira Braz Trans-A2B-Corroles are Superior Photosensitizers for Lung Cancer
Kılıç Novel Near-Ir Photosensitizers for Photodynamic Therapy and Designing Heavy Atom Free Photosensitizers for the Photodynamic Therapy
HK1160848B (en) Process for preparing chlorins and their pharmaceutical uses
BRPI0802649A2 (pt) derivados porfirìnicos, processo de obtenção e composição farmacêutica compreendendo os mesmos